Wells Fargo’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
|
|||||
|
2025
Q1 | $528K | Buy |
|
|||||
|
2024
Q4 | $557K | Buy |
|
|||||
|
2024
Q3 | $589K | Sell |
|
|||||
|
2024
Q2 | $640K | Buy |
|
|||||
|
2024
Q1 | $694K | Buy |
|
|||||
|
2023
Q4 | $495K | Sell |
|
|||||
|
2023
Q3 | $1.01M | Sell |
|
|||||
|
2023
Q2 | $1.86M | Buy |
|
|||||
|
2023
Q1 | $1.33M | Buy |
|
|||||
|
2022
Q4 | $129K | Sell |
|
|||||
|
2022
Q3 | $170K | Buy |
|
|||||
|
2022
Q2 | $122K | Sell |
|
|||||
|
2022
Q1 | $198K | Sell |
|
|||||
|
2021
Q4 | $572K | Buy |
|
|||||
|
2021
Q3 | $104K | Hold |
|
|||||
|
2021
Q2 | $94K | Sell |
|
|||||
|
2021
Q1 | $219K | Sell |
|
|||||
|
2020
Q4 | $1.38M | Sell |
|
|||||
|
2020
Q3 | $926K | Sell |
|
|||||
|
2020
Q2 | $1.29M | Buy |
|
|||||
|
2020
Q1 | $270K | Sell |
|
|||||
|
2019
Q4 | $530K | Buy |
|
|||||
|
2019
Q3 | $206K | Sell |
|
|||||
|
2019
Q2 | $365K | Sell |
|
|||||
|
2019
Q1 | $251K | Buy |
|
|||||
|
2018
Q4 | $192K | Buy |
|
|||||
|
2018
Q3 | $125K | Buy |
|
|||||
|
2018
Q2 | $76K | Buy |
|
|||||
|
2018
Q1 | $146K | Buy |
|
|||||
|
2017
Q4 | $81K | Buy |
|
|||||
|
2017
Q3 | $83K | Buy |
|
|||||
|
2017
Q2 | $23K | Hold |
|
|||||
|
2017
Q1 | $23K | Hold |
|
|||||
|
2016
Q4 | $12K | Hold |
|
|||||
|
2016
Q3 | $25K | Buy |
|